vs
OCULAR THERAPEUTIX, INC（OCUL）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
OCULAR THERAPEUTIX, INC的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.8倍（$13.3M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -488.0%，领先485.9%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -22.4%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-57.1M），过去两年Rocky Mountain Chocolate Factory, Inc.的营收复合增速更高（1.9% vs -5.3%）
Ocular Therapeutix是一家专注于眼科疗法研发和商业化的生物制药企业，核心产品覆盖术后疼痛、青光眼、干眼症等急慢性眼部疾病的治疗，主要服务美国及部分全球市场的眼科医疗机构与患者。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
OCUL vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $7.5M |
| 净利润 | $-64.7M | $-155.0K |
| 毛利率 | 88.0% | 34.0% |
| 营业利润率 | -526.5% | 1.1% |
| 净利率 | -488.0% | -2.1% |
| 营收同比 | -22.4% | -4.4% |
| 净利润同比 | -33.6% | 81.7% |
| 每股收益（稀释后） | $-0.27 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.3M | $7.5M | ||
| Q3 25 | $14.5M | $6.8M | ||
| Q2 25 | $13.5M | $6.4M | ||
| Q1 25 | $10.7M | $8.9M | ||
| Q4 24 | $17.1M | $7.9M | ||
| Q3 24 | $15.4M | $6.4M | ||
| Q2 24 | $16.4M | $6.4M | ||
| Q1 24 | $14.8M | $7.3M |
| Q4 25 | $-64.7M | $-155.0K | ||
| Q3 25 | $-69.4M | $-662.0K | ||
| Q2 25 | $-67.8M | $-324.0K | ||
| Q1 25 | $-64.1M | $-2.9M | ||
| Q4 24 | $-48.4M | $-847.0K | ||
| Q3 24 | $-36.5M | $-722.0K | ||
| Q2 24 | $-43.8M | $-1.7M | ||
| Q1 24 | $-64.8M | $-1.6M |
| Q4 25 | 88.0% | 34.0% | ||
| Q3 25 | 87.8% | 23.6% | ||
| Q2 25 | 85.6% | 31.1% | ||
| Q1 25 | 88.2% | 10.8% | ||
| Q4 24 | 92.8% | 23.4% | ||
| Q3 24 | 89.9% | 31.8% | ||
| Q2 24 | 90.8% | 12.8% | ||
| Q1 24 | 91.0% | 24.3% |
| Q4 25 | -526.5% | 1.1% | ||
| Q3 25 | -472.3% | -7.0% | ||
| Q2 25 | -502.6% | -2.3% | ||
| Q1 25 | -597.5% | -30.3% | ||
| Q4 24 | -296.1% | -8.9% | ||
| Q3 24 | -298.2% | -14.3% | ||
| Q2 24 | -265.1% | -25.4% | ||
| Q1 24 | -214.0% | -21.7% |
| Q4 25 | -488.0% | -2.1% | ||
| Q3 25 | -477.3% | -9.7% | ||
| Q2 25 | -503.9% | -5.1% | ||
| Q1 25 | -598.7% | -32.5% | ||
| Q4 24 | -283.3% | -10.7% | ||
| Q3 24 | -236.6% | -11.3% | ||
| Q2 24 | -266.3% | -25.9% | ||
| Q1 24 | -438.9% | -21.9% |
| Q4 25 | $-0.27 | $-0.02 | ||
| Q3 25 | $-0.38 | $-0.09 | ||
| Q2 25 | $-0.39 | $-0.04 | ||
| Q1 25 | $-0.38 | $-0.38 | ||
| Q4 24 | $-0.25 | $-0.11 | ||
| Q3 24 | $-0.22 | $-0.11 | ||
| Q2 24 | $-0.26 | $-0.26 | ||
| Q1 24 | $-0.49 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $737.1M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $654.3M | $6.0M |
| 总资产 | $808.1M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $737.1M | $641.0K | ||
| Q3 25 | $344.8M | $2.0M | ||
| Q2 25 | $391.1M | $893.0K | ||
| Q1 25 | $349.7M | $720.0K | ||
| Q4 24 | $392.1M | $1.1M | ||
| Q3 24 | $427.2M | $973.0K | ||
| Q2 24 | $459.7M | $637.0K | ||
| Q1 24 | $482.9M | $2.1M |
| Q4 25 | $654.3M | $6.0M | ||
| Q3 25 | $258.2M | $6.1M | ||
| Q2 25 | $305.9M | $6.7M | ||
| Q1 25 | $265.9M | $7.0M | ||
| Q4 24 | $315.3M | $9.8M | ||
| Q3 24 | $352.0M | $10.5M | ||
| Q2 24 | $377.7M | $9.0M | ||
| Q1 24 | $408.0M | $10.6M |
| Q4 25 | $808.1M | $20.7M | ||
| Q3 25 | $410.9M | $22.3M | ||
| Q2 25 | $451.3M | $20.1M | ||
| Q1 25 | $405.9M | $21.2M | ||
| Q4 24 | $457.9M | $21.6M | ||
| Q3 24 | $490.4M | $21.1M | ||
| Q2 24 | $517.1M | $19.0M | ||
| Q1 24 | $538.9M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-54.2M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-57.1M | $-1.3M |
| 自由现金流率自由现金流/营收 | -430.9% | -16.9% |
| 资本支出强度资本支出/营收 | 21.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-216.9M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-54.2M | $-1.2M | ||
| Q3 25 | $-50.7M | $-488.0K | ||
| Q2 25 | $-55.2M | $350.0K | ||
| Q1 25 | $-44.7M | $1.2M | ||
| Q4 24 | $-39.4M | $-2.1M | ||
| Q3 24 | $-36.6M | $-3.5M | ||
| Q2 24 | $-24.8M | $-2.2M | ||
| Q1 24 | $-33.9M | $129.0K |
| Q4 25 | $-57.1M | $-1.3M | ||
| Q3 25 | $-56.7M | $-544.0K | ||
| Q2 25 | $-56.5M | $182.0K | ||
| Q1 25 | $-46.6M | — | ||
| Q4 24 | $-39.6M | — | ||
| Q3 24 | $-36.6M | $-4.6M | ||
| Q2 24 | $-25.5M | $-2.6M | ||
| Q1 24 | $-34.1M | $-352.3K |
| Q4 25 | -430.9% | -16.9% | ||
| Q3 25 | -390.0% | -8.0% | ||
| Q2 25 | -419.7% | 2.9% | ||
| Q1 25 | -435.6% | — | ||
| Q4 24 | -232.0% | — | ||
| Q3 24 | -237.6% | -72.6% | ||
| Q2 24 | -155.4% | -40.2% | ||
| Q1 24 | -231.1% | -4.9% |
| Q4 25 | 21.4% | 0.5% | ||
| Q3 25 | 41.2% | 0.8% | ||
| Q2 25 | 9.3% | 2.6% | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 0.6% | 17.5% | ||
| Q2 24 | 4.5% | 6.5% | ||
| Q1 24 | 1.7% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OCUL
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
